Yeleswaram Krishnaswamy Insider Trading Activity
Yeleswaram Krishnaswamy has been net-selling over the last 12 months with 0 purchases and 11 sales across 1 company.
RAPP is the most-traded position with 11 trades. The largest single transaction was a sale of RAPP for $1.0M on Aug 25, 2026.
Performance Scorecard
Forward stock performance after each transaction by Yeleswaram Krishnaswamy. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -4.9% | 29% | 7 |
| 90 days | — | -14.3% | 0% | 7 |
| 120 days | — | -30.3% | 0% | 7 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersRAPP · Rapport Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Yeleswaram Krishnaswamy bought and sold RAPP.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Aug 25, 2026 | RAPP | Sell | 16,201 | $51.06 | $827K | −7.6% | Chief Development Officer | |
Aug 25, 2026 | RAPP | Sell | 20,799 | $50.31 | $1.0M | −8.9% | Chief Development Officer | |
Aug 24, 2026 | RAPP | Sell | 13,160 | $50.00 | $658K | −5.3% | Chief Development Officer | |
Aug 19, 2026 | RAPP | Sell | 404 | $49.90 | $20K | −0.2% | Chief Development Officer | |
Apr 17, 2026 | RAPP | Sell | 20,225 | $39.99 | $809K | −7.6% | Chief Development Officer | |
Apr 14, 2026 | RAPP | Sell | 10,200 | $35.08 | $358K | −3.7% | Chief Development Officer | |
Apr 13, 2026 | RAPP | Sell | 9,165 | $34.97 | $321K | −3.2% | Chief Development Officer | |
Apr 10, 2026 | RAPP | Sell | 500 | $34.98 | $17K | −0.2% | Chief Development Officer | |
Apr 8, 2026 | RAPP | Sell | 360 | $34.90 | $13K | −0.1% | Chief Development Officer | |
Mar 25, 2026 | RAPP | Sell | 10,115 | $29.99 | $303K | −3.4% | Chief Development Officer | |
Dec 31, 2025 Filed 3d late | RAPP | Sell | 2,840 | $30.05 | $85K | −0.9% | Chief Development Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | 11 | $4.5M |
Other insiders at Rapport Therapeutics, Inc.
4 other tracked filers at RAPP.